adalimumabhttp://www.unboundmedicine.com/medline/ebm/research/adalimumabUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.[Quality of life of patients with rheumatoid arthritis undergoing out-patient treatment with TNF inhibitors.]http://www.unboundmedicine.com/medline/ebm/record/18840348/full_citation/[Quality_of_life_of_patients_with_rheumatoid_arthritis_undergoing_out_patient_treatment_with_TNF_inhibitors_]Fernández Lisón LC, Vázquez Domínguez B, Luis Fernández J, et al. 
[Quality of life of patients with rheumatoid arthritis undergoing out-patient treatment with TNF inhibitors.] [English Abstract, Journal Article]
Farm Hosp 2008 May-Jun; 32(3):178-81.
Abstract | Full CitationBiological agents in the treatment of psoriasis.http://www.unboundmedicine.com/medline/ebm/record/18833073/full_citation/Biological_agents_in_the_treatment_of_psoriasis_Tzu J, Krulig E, Cardenas V, et al. 
Biological agents in the treatment of psoriasis. [Journal Article]
G Ital Dermatol Venereol 2008 Oct; 143(5):315-27.
Abstract | Full CitationAdalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study.http://www.unboundmedicine.com/medline/ebm/record/18831744/full_citation/Adalimumab_improves_health_related_quality_of_life_in_patients_with_moderate_to_severe_plaque_psoriasis_compared_with_the_United_States_general_population_norms:_Results_from_a_randomized_controlled_Phase_III_study_Revicki DA, Menter A, Feldman S, et al. 
Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study. [JOURNAL ARTICLE]
Health Qual Life Outcomes 2008 Oct 2; 6(1):75.
Abstract | Full Citation | Find Related Articles Closure of perianal fistula using adalimumab in a Crohn's disease patient naive to antitumor necrosis factor alpha antibodies.http://www.unboundmedicine.com/medline/ebm/record/18831523/full_citation/Closure_of_perianal_fistula_using_adalimumab_in_a_Crohn's_disease_patient_naive_to_antitumor_necrosis_factor_alpha_antibodies_Malesci A, Angelucci E, Bonifacio C, et al. 
Closure of perianal fistula using adalimumab in a Crohn's disease patient naive to antitumor necrosis factor alpha antibodies. [JOURNAL ARTICLE]
Inflamm Bowel Dis 2008 Oct 2.
Full Citation | Find Related Articles [Medical treatment of juvenile idiopathic arthritis]http://www.unboundmedicine.com/medline/ebm/record/18831464/full_citation/[Medical_treatment_of_juvenile_idiopathic_arthritis]Horneff G, Augustin S 
[Medical treatment of juvenile idiopathic arthritis] [English Abstract, Journal Article]
Med Monatsschr Pharm 2008 Sep; 31(9):326-36; quiz 337-8.
Abstract | Full CitationImpact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group.http://www.unboundmedicine.com/medline/ebm/record/18829616/full_citation/Impact_of_adalimumab_on_work_participation_in_rheumatoid_arthritis:_comparison_of_an_open_label_extension_study_and_a_registry_based_control_group_Halpern MT, Cifaldi MA, Kvien TK 
Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group. [JOURNAL ARTICLE]
Ann Rheum Dis 2008 Oct 1.
Abstract | Full Citation | Find Related Articles Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis.http://www.unboundmedicine.com/medline/ebm/record/18821658/full_citation/Effect_of_the_early_use_of_the_anti_tumor_necrosis_factor_adalimumab_on_the_prevention_of_job_loss_in_patients_with_early_rheumatoid_arthritis_Bejarano V, Quinn M, Conaghan PG, et al. 
Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis. [Journal Article]
Arthritis Rheum 2008 Oct 15; 59(10):1467-74.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Compliance with biologic therapies for rheumatoid arthritis: Do patient out-of-pocket payments matter?http://www.unboundmedicine.com/medline/ebm/record/18821651/full_citation/Compliance_with_biologic_therapies_for_rheumatoid_arthritis:_Do_patient_out_of_pocket_payments_matterCurkendall S, Patel V, Gleeson M, et al. 
Compliance with biologic therapies for rheumatoid arthritis: Do patient out-of-pocket payments matter? [Journal Article]
Arthritis Rheum 2008 Oct 15; 59(10):1519-26.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Efficacy of adalimumab, etanercept, and infliximab in psoriatic arthritis based on ACR50 response after 24 weeks of treatment.http://www.unboundmedicine.com/medline/ebm/record/18821278/full_citation/Efficacy_of_adalimumab_etanercept_and_infliximab_in_psoriatic_arthritis_based_on_ACR50_response_after_24_weeks_of_treatment_Brodszky V, Pentek M, Gulacsi L 
Efficacy of adalimumab, etanercept, and infliximab in psoriatic arthritis based on ACR50 response after 24 weeks of treatment. [Letter]
Scand J Rheumatol 2008 Sep-Oct; 37(5):399-400.
Full Citation | Find Related Articles Miller-Fisher syndrome in a patient with rheumatoid arthritis treated with adalimumab.http://www.unboundmedicine.com/medline/ebm/record/18818868/full_citation/Miller_Fisher_syndrome_in_a_patient_with_rheumatoid_arthritis_treated_with_adalimumab_Kurmann PT, Van Linthoudt D, So AK 
Miller-Fisher syndrome in a patient with rheumatoid arthritis treated with adalimumab. [JOURNAL ARTICLE]
Clin Rheumatol 2008 Sep 26.
Abstract | Full Citation